Literature DB >> 31965157

Application of a gut-immune co-culture system for the study of N-glycan-dependent host-pathogen interactions of Campylobacter jejuni.

Cristina Y Zamora1,2, Elizabeth M Ward1,3, Jemila C Kester4, Wen Li Kelly Chen4, Jason G Velazquez4, Linda G Griffith4,5, Barbara Imperiali1,2.   

Abstract

An in vitro gut-immune co-culture model with apical and basal accessibility, designed to more closely resemble a human intestinal microenvironment, was employed to study the role of the N-linked protein glycosylation pathway in Campylobacter jejuni pathogenicity. The gut-immune co-culture (GIC) was developed to model important aspects of the human small intestine by the inclusion of mucin-producing goblet cells, human enterocytes and dendritic cells, bringing together a mucus-containing epithelial monolayer with elements of the innate immune system. The utility of the system was demonstrated by characterizing host-pathogen interactions facilitated by N-linked glycosylation, such as host epithelial barrier functions, bacterial invasion and immunogenicity. Changes in human intestinal barrier functions in the presence of 11168 C. jejuni (wildtype) strains were quantified using GICs. The glycosylation-impaired strain 11168 ΔpglE was 100-fold less capable of adhering to and invading this intestinal model in cell infectivity assays. Quantification of inflammatory signaling revealed that 11168ΔpglE differentially modulated inflammatory responses in different intestinal microenvironments, suppressive in some but activating in others. Virulence-associated outer membrane vesicles produced by wildtype and 11168ΔpglE C. jejuni were shown to have differential composition and function, with both leading to immune system activation when provided to the gut-immune co-culture model. This analysis of aspects of C. jejuni infectivity in the presence and absence of its N-linked glycome is enabled by application of the gut-immune model, and we anticipate that this system will be applicable to further studies of C. jejuni and other enteropathogens of interest.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 Campylobacter jejunizzm321990 ; N-linked glycosylation; bacterial virulence; enteropathogens; intestinal models of infection

Year:  2020        PMID: 31965157      PMCID: PMC7234929          DOI: 10.1093/glycob/cwz105

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  46 in total

1.  Campylobacter jejuni induces maturation and cytokine production in human dendritic cells.

Authors:  Lan Hu; Mechelle D Bray; Manuel Osorio; Dennis J Kopecko
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 2.  Sweet Talk: Protein Glycosylation in Bacterial Interaction With the Host.

Authors:  Qiuhe Lu; Shan Li; Feng Shao
Journal:  Trends Microbiol       Date:  2015-10       Impact factor: 17.079

3.  Identification of N-acetylgalactosamine-containing glycoproteins PEB3 and CgpA in Campylobacter jejuni.

Authors:  Dennis Linton; Elaine Allan; Andrey V Karlyshev; Andrew D Cronshaw; Brendan W Wren
Journal:  Mol Microbiol       Date:  2002-01       Impact factor: 3.501

4.  Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro.

Authors:  Patricia Guerry; Christine M Szymanski; Martina M Prendergast; Thomas E Hickey; Cheryl P Ewing; Dawn L Pattarini; Anthony P Moran
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

Review 5.  Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions.

Authors:  Carmen Schwechheimer; Meta J Kuehn
Journal:  Nat Rev Microbiol       Date:  2015-10       Impact factor: 60.633

6.  Motility of Campylobacter jejuni in a viscous environment: comparison with conventional rod-shaped bacteria.

Authors:  R L Ferrero; A Lee
Journal:  J Gen Microbiol       Date:  1988-01

7.  Campylobacter jejuni response to human mucin MUC2: modulation of colonization and pathogenicity determinants.

Authors:  Quoc V Tu; Michael A McGuckin; George L Mendz
Journal:  J Med Microbiol       Date:  2008-07       Impact factor: 2.472

8.  Campylobacter jejuni outer membrane vesicles play an important role in bacterial interactions with human intestinal epithelial cells.

Authors:  Abdi Elmi; Eleanor Watson; Pamela Sandu; Ozan Gundogdu; Dominic C Mills; Neil F Inglis; Erin Manson; Lisa Imrie; Mona Bajaj-Elliott; Brendan W Wren; David G E Smith; Nick Dorrell
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

9.  Adaptation of Campylobacter jejuni NCTC11168 to high-level colonization of the avian gastrointestinal tract.

Authors:  Michael A Jones; Kerrie L Marston; Claire A Woodall; Duncan J Maskell; Dennis Linton; Andrey V Karlyshev; Nick Dorrell; Brendan W Wren; Paul A Barrow
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

Review 10.  Interactions of Intestinal Bacteria with Components of the Intestinal Mucus.

Authors:  Jean-Félix Sicard; Guillaume Le Bihan; Philippe Vogeleer; Mario Jacques; Josée Harel
Journal:  Front Cell Infect Microbiol       Date:  2017-09-05       Impact factor: 5.293

View more
  3 in total

Review 1.  Intestinal Organoids: New Tools to Comprehend the Virulence of Bacterial Foodborne Pathogens.

Authors:  Mayra Aguirre Garcia; Killian Hillion; Jean-Michel Cappelier; Michel Neunlist; Maxime M Mahe; Nabila Haddad
Journal:  Foods       Date:  2022-01-01

2.  Reactive oxygen species limit intestinal mucosa-bacteria homeostasis in vitro.

Authors:  Joshua Luchan; Christian Choi; Rebecca L Carrier
Journal:  Sci Rep       Date:  2021-12-09       Impact factor: 4.379

3.  Coculture of primary human colon monolayer with human gut bacteria.

Authors:  Jianbo Zhang; Victor Hernandez-Gordillo; Martin Trapecar; Charles Wright; Mao Taketani; Kirsten Schneider; Wen Li Kelly Chen; Eric Stas; David T Breault; Rebecca L Carrier; Christopher A Voigt; Linda G Griffith
Journal:  Nat Protoc       Date:  2021-06-28       Impact factor: 17.021

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.